- First New Erectile Dysfunction Drug in a Decade.
- Sales Already Impressing.
- Vivus Needs A Winner After Sluggish Qsymia Sales.
VIVUS is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.